Black Rock Inc. Ionis Pharmaceuticals Inc Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Black Rock Inc. holds 10,321,030 shares of IONS stock, worth $384 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,321,030
Previous 9,771,891
5.62%
Holding current value
$384 Million
Previous $424 Million
16.12%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding IONS
# of Institutions
400Shares Held
136MCall Options Held
882KPut Options Held
476K-
Vanguard Group Inc Valley Forge, PA15.1MShares$561 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$527 Million0.34% of portfolio
-
Wellington Management Group LLP Boston, MA8.74MShares$325 Million0.06% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$293 Million5.32% of portfolio
-
Capital World Investors Los Angeles, CA7.83MShares$291 Million0.05% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.28B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...